Notice: This company has been marked as potentially delisted and may not be actively trading. Histogenics (HSGX) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends HSGX vs. SMTI, INGN, LAKE, ZJYL, RBOT, MLSS, APT, SPAI, NTRB, and CLGNShould you be buying Histogenics stock or one of its competitors? The main competitors of Histogenics include Sanara MedTech (SMTI), Inogen (INGN), Lakeland Industries (LAKE), Jin Medical International (ZJYL), Vicarious Surgical (RBOT), Milestone Scientific (MLSS), Alpha Pro Tech (APT), Safe Pro Group Inc. Common Stock (SPAI), Nutriband (NTRB), and CollPlant Biotechnologies (CLGN). Histogenics vs. Sanara MedTech Inogen Lakeland Industries Jin Medical International Vicarious Surgical Milestone Scientific Alpha Pro Tech Safe Pro Group Inc. Common Stock Nutriband CollPlant Biotechnologies Sanara MedTech (NASDAQ:SMTI) and Histogenics (NASDAQ:HSGX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, media sentiment, community ranking, dividends and earnings. Is SMTI or HSGX more profitable? Histogenics has a net margin of 0.00% compared to Sanara MedTech's net margin of -10.71%. Sanara MedTech's return on equity of -19.86% beat Histogenics' return on equity.Company Net Margins Return on Equity Return on Assets Sanara MedTech-10.71% -19.86% -10.91% Histogenics N/A -34.96%18.40% Which has stronger valuation & earnings, SMTI or HSGX? Sanara MedTech has higher revenue and earnings than Histogenics. Sanara MedTech is trading at a lower price-to-earnings ratio than Histogenics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSanara MedTech$78.06M3.77-$4.30M-$0.99-34.02HistogenicsN/AN/A-$8.64M-$0.79-0.97 Which has more volatility & risk, SMTI or HSGX? Sanara MedTech has a beta of 1.57, indicating that its stock price is 57% more volatile than the S&P 500. Comparatively, Histogenics has a beta of 3.1, indicating that its stock price is 210% more volatile than the S&P 500. Do analysts rate SMTI or HSGX? Sanara MedTech presently has a consensus price target of $44.00, indicating a potential upside of 30.64%. Given Sanara MedTech's stronger consensus rating and higher possible upside, analysts plainly believe Sanara MedTech is more favorable than Histogenics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sanara MedTech 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Histogenics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals & insiders hold more shares of SMTI or HSGX? 8.1% of Sanara MedTech shares are held by institutional investors. Comparatively, 40.4% of Histogenics shares are held by institutional investors. 54.1% of Sanara MedTech shares are held by company insiders. Comparatively, 19.7% of Histogenics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media prefer SMTI or HSGX? In the previous week, Sanara MedTech's average media sentiment score of 0.00 equaled Histogenics'average media sentiment score. Company Overall Sentiment Sanara MedTech Neutral Histogenics Neutral Does the MarketBeat Community favor SMTI or HSGX? Histogenics received 341 more outperform votes than Sanara MedTech when rated by MarketBeat users. Likewise, 71.66% of users gave Histogenics an outperform vote while only 54.55% of users gave Sanara MedTech an outperform vote. CompanyUnderperformOutperformSanara MedTechOutperform Votes1854.55% Underperform Votes1545.45% HistogenicsOutperform Votes35971.66% Underperform Votes14228.34% SummaryHistogenics beats Sanara MedTech on 8 of the 15 factors compared between the two stocks. Ad Stansberry Research$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.Click here to see his new research now. Get Histogenics News Delivered to You Automatically Sign up to receive the latest news and ratings for HSGX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSGX vs. The Competition Export to ExcelMetricHistogenicsSurgical Appliances & Supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$72.64M$9.52B$5.14B$9.08BDividend YieldN/A1.38%5.09%4.23%P/E Ratio-0.9719.5690.1317.19Price / SalesN/A32.801,116.25117.05Price / CashN/A22.3743.1037.85Price / Book-76.795.494.784.78Net Income-$8.64M$182.72M$120.31M$225.60M Histogenics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSGXHistogenicsN/A$0.77+1.8%N/A+89.0%$72.64MN/A-0.9749Gap UpSMTISanara MedTech1.9962 of 5 stars$33.76-2.6%$44.00+30.3%-13.9%$295.06M$64.99M-35.0060INGNInogen2.5647 of 5 stars$8.94-0.2%$7.00-21.7%+43.5%$212.93M$331.52M-3.98834Analyst DowngradeNews CoverageLAKELakeland Industries4.5789 of 5 stars$23.74+4.6%$26.50+11.6%+26.0%$175.82M$151.82M-252.221,750Analyst ForecastAnalyst RevisionNews CoverageZJYLJin Medical InternationalN/A$0.78+0.1%N/A-98.8%$120.75M$19.82M0.00245Gap DownRBOTVicarious Surgical1.2841 of 5 stars$14.40+1.4%$10.25-28.8%+3.5%$85.08MN/A-1.383Positive NewsMLSSMilestone Scientific2.1626 of 5 stars$0.83+2.6%$1.25+50.4%+57.4%$64.73M$8.88M-11.5730Analyst ForecastNews CoverageAPTAlpha Pro TechN/A$5.22-0.6%N/A+1.7%$57.42M$59.29M14.19120SPAISafe Pro Group Inc. Common StockN/A$4.07-8.7%N/AN/A$56.00M$1.56M0.0011News CoveragePositive NewsNTRBNutriband0.408 of 5 stars$4.37+5.6%N/A+60.0%$48.53M$2.02M-5.8310Positive NewsGap UpCLGNCollPlant Biotechnologies2.136 of 5 stars$3.67-0.5%$12.50+240.6%-35.0%$42.02M$10.96M-2.3870Positive News Related Companies and Tools Related Companies SMTI Competitors INGN Competitors LAKE Competitors ZJYL Competitors RBOT Competitors MLSS Competitors APT Competitors SPAI Competitors NTRB Competitors CLGN Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HSGX) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Histogenics Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Histogenics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
